Larger Abdomen in Midlife
Increases Risk of Dementia
Overweight
Individuals with Large Bellies Double or Triple the Risk of Dementia
People
in their 40s with bigger stomachs experience a greater risk for dementia in their
70s, according to a study published in the March 26, 2008, online issue of Neurology(R),
the journal published by the American
Academy of Neurology.
Earlier
studies looked at central obesity (as determined by waist circumference) and body
mass index in the elderly and its relationship to dementia risk.
Also,
earlier studies revealed that a large midlife abdomen increases the risk of coronary
heart disease, stroke, and diabetes.
This
most recent study, however, is the first time researchers have shown a longitudinal
association between midlife belly fat and risk of dementia.
Measuring
abdominal obesity in midlife may be a much better indicator of the long term metabolic
problems that increase dementia risk, said Rachel Whitmer, Ph.D., the research
scientist at the Kaiser Permanente Division of Research in Oakland, CA,
who authored this study.
Measuring
abdomen size in older people may not be as good an indicator because as people
get older they naturally gain belly size as they lose muscle and bone mass, she
explained.
"Considering
that 50 percent of adults in this country have abdominal obesity, this is a disturbing
finding. It is well known that being overweight in midlife and beyond increases
risk factors for disease. However, where one carries the weight -- especially
in midlife -- appears to be an important predictor for dementia risk," Whitmer
said.
"Autopsies
have shown that changes in the brain associated with Alzheimer's disease may start
in young to middle adulthood, and another study showed that high abdominal fat
in elderly adults was tied to greater brain atrophy. These findings imply that
the dangerous effects of abdominal obesity on the brain may start long before
the signs of dementia appear."
Whitmer
pointed out that more research must be completed to understand the various mechanisms
that link abdominal obesity in midlife to dementia risk.
The
study measured the abdominal density of 6,583 people age 40 to 45 in northern
California. Belly fat was determined with a caliper measuring the distance from
the back to the upper abdomen, halfway between the top of the pelvis and the bottom
of the ribs.
Belly
density was highly correlated with the fat tissue (called visceral fat tissue)
wrapped around the organs. An average of 36 years later, doctors had diagnosed
16 percent of the participants with dementia.
The
study revealed that overweight people with a large belly were 2.3 times more likely
to develop dementia than men and women carrying normal weight and belly size.
Obese
adults with large bellies had a 3.6 times better chance of developing dementia
than those of normal weight and belly size.
Overweight
or obese people who didn't have large abdomens still had an 80% increased risk
of dementia.
Having
a big belly increased the risk of dementia regardless of whether the participants
were overweight, obese, or of normal weight overall and regardless of existing
health conditions, including cardiovascular disease, diabetes, and stroke.
Individuals
more likely to have abdominal obesity included non-whites, smokers, people experiencing
high blood pressure, high cholesterol or diabetes, and those who didn't complete
high school.
In
conclusion, as is the case with all observational studies, the association of
the abdominal obesity and dementia may not be driven solely by abdominal obesity,
but may well include a complex set of health-related issues, of which abdominal
obesity is just one.
Note
from Chet: If you're serious about losing the weight around your middle and
thus decreasing your chance of dementia in your old age, check out our favorite
belly fat reducing system, Truth
About Six Pack Abs Program.
Disclaimer:
Throughout this website, statements are made pertaining to the properties and/or
functions of food and/or nutritional products. These statements have not been
evaluated by the Food and Drug Administration and these materials and products
are not intended to diagnose, treat, cure or prevent any disease.